The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Heumann Pharma Generica competitive analysis

Loading summary...

Latest oppositions filed by Heumann Pharma Generica

Explore patent oppositions filed by Heumann Pharma Generica against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 13, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP2959894
S1P Receptor Modulators For Treating Multiple SclerosisNOVARTISDec 5, 2022
EP1856051
Amorphous Lercanidipine HydrochlorideRECORDATI INDUSTRIA CHIMICA E FARMACEUTICAAug 4, 2020

Latest PTAB cases involving Heumann Pharma Generica

Discover the latest PTAB cases involving Heumann Pharma Generica, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Heumann Pharma Generica with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
HEUMANN PHARMA GENERICA2 - - -
NOVARTIS6422 - 21
RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA - 7 - -
RECORDATI IRELAND - 7 - -